Every year The European League Against Rheumatism (EULAR), which is an E.U.-based organization that represents the patient, healthcare professional and professional societies of rheumatology, holds the Annual European Congress of Rheumatology. This forum serves as a space where rheumatology professionals can connect with patient organizations, as well as to learn and engage with other professionals in rheumatology, all to achieve progress in the care of people who suffer from various autoimmune and inflammatory diseases.

This year’s conference took place in Madrid, Spain. Among the thousands of presentations, one scientific session that stood out to me (in my review of the gathering) was a meta-analysis conducted by Bruno Fautrel, MD, PhD, of the Departments of Epidemiology, Rheumatology and Clinical Immunology (from Pierre and Marie Curie University in Paris), and his colleagues. Their study suggests that the best way for patients with pre-rheumatoid arthritis to prevent a full onset of rheumatoid arthritis is to intervene with early therapy.

Patients who have pre-rheumatoid arthritis are at an important point in their medical care because this is the ideal time period to prevent full onset of rheumatoid arthritis. Patients and their providers should take into consideration contributing risk factors, such as smoking and obesity, and adjust their lifestyle accordingly. However, Fautrel and his colleagues conducted a meta-analysis of people with the disease and found that medical treatment could effectively prevent progression to rheumatoid arthritis.

To read more about the findings of this meta-analysis, visit Micha Abeles’ blog here.

Advertisements